| Breakdown | TTM | Mar 2024 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.13M | 2.82M | 1.47M | 442.00K | 45.00K | 2.83M |
| Gross Profit | 767.41K | 929.00K | 271.00K | -133.00K | 47.00K | -239.00K |
| EBITDA | -1.77M | -2.25M | -1.15M | -1.09M | -762.00K | -306.00K |
| Net Income | -2.45M | -2.19M | -1.22M | -1.63M | -1.43M | -490.00K |
Balance Sheet | ||||||
| Total Assets | 54.76M | 47.02M | 7.50M | 6.70M | 8.21M | 4.61M |
| Cash, Cash Equivalents and Short-Term Investments | 3.91M | 4.21M | 2.61M | 4.25M | 5.10M | 1.74M |
| Total Debt | 191.89K | 126.00K | 212.00K | 381.00K | 1.31M | 1.78M |
| Total Liabilities | 44.64M | 38.57M | 1.25M | 2.83M | 2.20M | 2.79M |
| Stockholders Equity | 10.30M | 8.50M | 6.30M | 3.87M | 6.01M | 1.82M |
Cash Flow | ||||||
| Free Cash Flow | -2.83M | -2.75M | -5.13M | 157.00K | -1.92M | -1.07M |
| Operating Cash Flow | -3.08M | -1.88M | -3.05M | 2.11M | -1.76M | -915.00K |
| Investing Cash Flow | -1.91M | -1.09M | -2.08M | -1.52M | -159.00K | -106.00K |
| Financing Cash Flow | 5.98M | 4.57M | 3.48M | -1.44M | 5.28M | 2.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £50.55M | 14.63 | 38.65% | 2.69% | 30.01% | 138.65% | |
69 Neutral | £51.13M | 15.19 | 12.27% | ― | 20.40% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £183.21M | 18.70 | 4.57% | 3.01% | -31.46% | 297.44% | |
52 Neutral | £29.55M | -2.77 | -18.74% | ― | -5.84% | 55.30% | |
50 Neutral | £12.97M | -4.40 | -67.57% | ― | -12.11% | -106.04% | |
41 Neutral | £5.81M | -17.66 | -29.54% | ― | -44.27% | -350.00% |